Synovus Financial’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.38M | Buy |
24,331
+520
| +2% | +$53.9K | 0.03% | 332 |
|
|
2025
Q2 | $2.56M | Buy |
23,811
+762
| +3% | +$77.1K | 0.03% | 305 |
|
|
2025
Q1 | $2.33M | Buy |
23,049
+5,602
| +32% | +$564K | 0.03% | 322 |
|
|
2024
Q4 | $1.56M | Sell |
17,447
-71
| -0.4% | -$6.25K | 0.02% | 392 |
|
|
2024
Q3 | $1.47M | Buy |
17,518
+1,167
| +7% | +$92K | 0.02% | 427 |
|
|
2024
Q2 | $1.26M | Sell |
16,351
-35
| -0.2% | -$2.56K | 0.02% | 416 |
|
|
2024
Q1 | $1.12M | Sell |
16,386
-232
| -1% | -$14.9K | 0.01% | 433 |
|
|
2023
Q4 | $961K | Buy |
16,618
+418
| +3% | +$22.3K | 0.01% | 439 |
|
|
2023
Q3 | $855K | Buy |
16,200
+10,226
| +171% | +$536K | 0.01% | 479 |
|
|
2023
Q2 | $323K | Buy |
5,974
+32
| +0.5% | +$1.67K | ﹤0.01% | 710 |
|
|
2023
Q1 | $297K | Sell |
5,942
-38
| -0.6% | -$1.79K | ﹤0.01% | 724 |
|
|
2022
Q4 | $277K | Buy |
5,980
+14
| +0.2% | +$606 | ﹤0.01% | 750 |
|
|
2022
Q3 | $230K | Buy |
5,966
+214
| +4% | +$8.59K | ﹤0.01% | 760 |
|
|
2022
Q2 | $215K | Buy |
+5,752
| New | +$234K | ﹤0.01% | 791 |
|
|
2022
Q1 | – | Sell |
-5,752
| Closed | -$245K | – | 848 |
|
|
2021
Q4 | $245K | Hold |
5,752
| – | – | ﹤0.01% | 787 |
|
|
2021
Q3 | $249K | Hold |
5,752
| – | – | ﹤0.01% | 766 |
|
|
2021
Q2 | $245K | Sell |
5,752
-523
| -8% | -$22K | ﹤0.01% | 761 |
|
|
2021
Q1 | $242K | Sell |
6,275
-3,667
| -37% | -$139K | ﹤0.01% | 691 |
|
|
2020
Q4 | $357K | Sell |
9,942
-200
| -2% | -$7.21K | ﹤0.01% | 612 |
|
|
2020
Q3 | $387K | Sell |
10,142
-160
| -2% | -$6.17K | 0.01% | 552 |
|
|
2020
Q2 | $362K | Sell |
10,302
-7,457
| -42% | -$269K | 0.01% | 535 |
|
|
2020
Q1 | $581K | Buy |
17,759
+7,700
| +77% | +$301K | 0.01% | 484 |
|
|
2019
Q4 | $455K | Buy |
10,059
+341
| +4% | +$14.3K | 0.01% | 489 |
|
|
2019
Q3 | $394K | Buy |
9,718
+1,486
| +18% | +$63K | 0.01% | 514 |
|
|
2019
Q2 | $354K | Buy |
8,232
+2,361
| +40% | +$90.8K | 0.01% | 516 |
|
|
2019
Q1 | $226K | Hold |
5,871
| – | – | ﹤0.01% | 557 |
|
|
2018
Q4 | $207K | Buy |
5,871
+871
| +17% | +$31.6K | ﹤0.01% | 557 |
|
|
2018
Q3 | $191K | Buy |
5,000
+1,356
| +37% | +$47.4K | ﹤0.01% | 596 |
|
|
2018
Q2 | $120K | Buy |
3,644
+40
| +1% | +$1.21K | ﹤0.01% | 653 |
|
|
2018
Q1 | $99K | Buy |
+3,604
| New | +$98K | ﹤0.01% | 677 |
|
|
2017
Q2 | – | Sell |
-4,105
| Closed | -$102K | – | 818 |
|
|
2017
Q1 | $102K | Sell |
4,105
-127
| -3% | -$3.09K | ﹤0.01% | 628 |
|
|
2016
Q4 | $92K | Sell |
4,232
-71
| -2% | -$1.55K | ﹤0.01% | 630 |
|
|
2016
Q3 | $102K | Buy |
+4,303
| New | +$103K | ﹤0.01% | 603 |
|
Other funds holding BSX
Synovus Financial's BSX Position: Q3 2025 in Review
Synovus Financial increased its Boston Scientific (BSX) stake by 2.2% in Q3 2025, buying an estimated $53.9K and bringing the position to 24,331 shares worth $2.38M. The position accounts for 0.03% of the portfolio, ranked #332.
Synovus Financial first reported a position in BSX in Q3 2016 and has held it in 33 quarters since. The position peaked at $2.56M in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.
- Synovus Financial held 24,331 shares of Boston Scientific worth $2.38M as of Q3 2025.
- Synovus Financial bought 520 Boston Scientific shares in Q3 2025, an estimated $53.9K.
- Boston Scientific made up 0.03% of Synovus Financial's portfolio in Q3 2025, its #332 holding.
- Synovus Financial first reported a position in Boston Scientific in Q3 2016 and has held it in 33 quarters since.
- Synovus Financial's Boston Scientific position peaked at $2.56M in Q2 2025.
- 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.
Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.